| Predicate |
Object |
| contentType |
Case Reports|Journal Article |
| endingPage |
6 |
| issn |
1545-9616 |
| issueIdentifier |
5 |
| pageRange |
554-6 |
| publicationName |
Journal of drugs in dermatology : JDD |
| startingPage |
554 |
| bibliographicCitation |
Jensen SL, Holmes R. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy. J Drugs Dermatol. 2003 Oct;2(5):554–6. PMID: 14558405. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88dc3fda25a5209b1bee8b8d0b3ae070
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41bbf5a636f18074c6fa20b96957482a |
| date |
200310 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/14558405 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30387
https://portal.issn.org/resource/ISSN/1545-9616 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy |
| discusses |
http://id.nlm.nih.gov/mesh/M0018641
http://id.nlm.nih.gov/mesh/M0552528
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0374956
http://id.nlm.nih.gov/mesh/M0017182
http://id.nlm.nih.gov/mesh/M0019062
http://id.nlm.nih.gov/mesh/M0263641
http://id.nlm.nih.gov/mesh/M0025711 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011092
http://id.nlm.nih.gov/mesh/D012393Q000139
http://id.nlm.nih.gov/mesh/D016898Q000009
http://id.nlm.nih.gov/mesh/D000998Q000009
http://id.nlm.nih.gov/mesh/D012254Q000009 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000077190
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D011994
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D006526Q000188
http://id.nlm.nih.gov/mesh/D008875 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7996
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542 |